JACC and The Lancet Align to Advance Cardiovascular Health

Journal collaboration will accelerate progress in the promotion of cardiovascular health.

Contact: Olivia Walther, owalther@acc.org,

WASHINGTON (May 09, 2024) -

JACC, the flagship journal of the American College of Cardiology, and The Lancet are bringing together their resources, expertise, and networks to disseminate high-quality research, foster interdisciplinary collaborations, and advance cardiovascular health worldwide. Through close collaboration, bringing together JACC's stature in cardiology and The Lancet's influence in general medicine, they are uniting to enhance their joint impact on global health by publishing, disseminating, and amplifying the highest quality research.

"The synergy between JACC's comprehensive focus on cardiovascular health and The Lancet's wide-reaching influence in general medicine creates a formidable alliance to advance health worldwide," said Harlan M. Krumholz, MD, SM, FACC, Incoming JACC Editor-in-Chief. "United in our vision, we are set to amplify our joint impact, pushing the boundaries of what academic journals can achieve for patients and society."

Together, JACC and The Lancet will aim to enhance the strength, diversity, and quality of research published in each journal to better serve authors and readers. The journals, both published by Elsevier, will support authors who seek publication in JACC and The Lancet with the option of a seamless manuscript transfer system. In partnership with the research and clinical community, the journals will also spearhead Commissions on urgent health topics to advance clinical care and public policy and collaborate on expert commentary to explore further the issues impacting the prevention and treatment of cardiovascular disease worldwide and identify avenues for rapid progress.

 “Through the partnership between JACC and The Lancet, we will be providing world-leading cardiologists with an unparalleled platform to advance and promote their research and drive improvements in clinical care, for the benefit of patients,” said Dr. Richard Horton, Editor-in-Chief at The Lancet.

Together, the journals are poised to transform the dissemination and application of groundbreaking research and practice-changing science through their respective channels. This initiative will bring heightened attention to applying evidence-based solutions for critical health issues and highlight each organization’s dedication to enhancing health outcomes globally.

The American College of Cardiology (ACC) is the global leader in transforming cardiovascular care and improving heart health for all. As the preeminent source of professional medical education for the entire cardiovascular care team since 1949, ACC credentials cardiovascular professionals in over 140 countries who meet stringent qualifications and leads in the formation of health policy, standards and guidelines. Through its world-renowned family of JACC Journals, NCDR registries, ACC Accreditation Services, global network of Member Sections, CardioSmart patient resources and more, the College is committed to ensuring a world where science, knowledge and innovation optimize patient care and outcomes. Learn more at www.ACC.org or follow @ACCinTouch.

The ACC’s family of JACC Journals rank among the top cardiovascular journals in the world for scientific impact. The flagship journal, the Journal of the American College of Cardiology (JACC) — and family of specialty journals consisting of JACC: Advances, JACC: Asia, JACC: Basic to Translational Science, JACC: CardioOncology, JACC: Cardiovascular Imaging, JACC: Cardiovascular Interventions, JACC: Case Reports, JACC: Clinical Electrophysiology and JACC: Heart Failure — pride themselves on publishing the top peer-reviewed research on all aspects of cardiovascular disease. Learn more at JACC.org.

The Lancet is an independent, international weekly general medical journal publishing the best science from the best scientists worldwide, providing an unparalleled global reach and impact on health. Since its first issue (Oct 5, 1823), the journal has strived to make science widely available so that medicine can serve and transform society, and positively impact the lives of people. The Lancet is a world-leading source of clinical, public health, and global health knowledge. The journal has an Impact Factor of 168·9 (2022 Journal Citation Reports®, Clarivate 2023) and ranks first among 167 general and internal medicine journals globally, and a Scopus CiteScore of 133·2—ranking second among 830 general medicine journals. Find out more about The Lancet


< Back to Listings